Bharat Misra is a Gastroenterology physician affiliated with Borland Groover Clinic. OpenAlex indexes 27 publications with 636 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
83.9%Proton pump inhibitor40.6%Pantoprazole Sodium73%Omeprazole27%Part D≥111 patientsOsmotic Laxative11.8%Gavilyte-G56%Lactulose25%Peg-3350 And Electrolytes19%Part D≥73 patients+ 8 more classes in this area
Anti-infectives
8.3%Glycopeptide Antibacterial3.2%Vancomycin Hcl100%Part D<11 patientsPenicillins with extended spectrum2.3%Amoxicillin-Clavulanate Potass100%Part D≥15 patients+ 2 more classes in this area
Cardiovascular
4.6%Bile Acid Sequestrant3.1%Cholestyramine68%Colesevelam Hcl32%Part D<11 patientsAldosterone antagonist (MRA)1.5%Spironolactone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Artificial Intelligence for Real-Time Prediction of the Histology of Colorectal Polyps by General Endoscopists
Annals of Internal Medicine
2024 - Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
Infectious Diseases and Therapy
2024 - Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
Infectious Diseases and Therapy
2024
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”